Textbook Outcomes in Urgent Appendectomy (APPX_TEXTBOOK)

January 2, 2025 updated by: Ana María González Castillo, Hospital del Mar

Textbook Outcomes of Surgical Treatment of Acute Appendicitis

A "textbook outcome" patient is defined as one whose surgical course is uneventful, with no complications, readmissions, or mortality. There is a lack of published research regarding textbook outcomes with an acute appendicitis that are treated with an appendectomy.

Study Overview

Status

Not yet recruiting

Detailed Description

The objective of this study is to analyze the attainment of textbook outcomes (TO) in patients undergoing urgent appendicectomy (UA) for acute appendicitis and to identify the factors associated with achieving TO.

Study Type

Observational

Enrollment (Estimated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

All the admissions with diagnostic of Acute Appendicitis in an University Hospital

Description

Inclusion Criteria:

  • Acute Appendicits in older than 18 years old
  • Acute Appendicitis that needs appendectomy

Exclusion Criteria:

  • Age under 18 years old
  • Other diagnostic than an Acute Appendicitis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Textbook Outcomes
Time Frame: 2022-2024
Classical assessments, focused solely on mortality and morbidity, are increasingly considered insufficient. A more comprehensive approach, using composite measures, offers a more accurate evaluation, providing a multidimensional view and patient-centred healthcare appraisal. The textbook outcome (TO) is the most used objective composite measure to compare surgical quality across centres
2022-2024

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Appendectomy in less than 24h
Time Frame: 2022-2024
From diagnostic of Acute Appendicitus to Surgical Treatment should be less than 24h
2022-2024
Hospital Stay less than 5 days
Time Frame: 2022-2024
Optimal hospital stay should be less than 5 days
2022-2024
Intraoperative incidences
Time Frame: 2022-2024
Intraoperative bleeding, perforation of the appendix, iatrogenic injury to other structures
2022-2024
Short antibiotics treatment
Time Frame: 2022-2024
Less than 72h of antibiotic treatment
2022-2024
Patient comorbidities
Time Frame: 2022-2024
Charlson Comorbidity Index
2022-2024
Surgical Risk
Time Frame: 2022-2024
ASA Scoring System
2022-2024
Intraoperative appendicitis gradding
Time Frame: 2022-2024

AAST classification AAST I: Acutely inflamed appendix, intact. AAST II:Gangrenous appendix, intact AAST III:Above, with evidence of local contamination AAST IV:Above, with abscess or phlegmon in region of appendix AAST V:Above, with addition of generalized purulent contamination away from appendix

WSES Classification:

Grade- 0 (normal looking) Grade-1 (inflamed) Grade- 2A and 2B (necrosis) Grade- 3A - 3B - 3C (perforated - inflammatory tumor) Grade- 4 (perforate - diffuse peritonitis)

2022-2024
Postperative complications
Time Frame: 2022-2024

Clavien Dindo and CCI (https://www.cci-calculator.com/)

Grade I: Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic, and radiological interventions.

Grade II:Requiring pharmacological treatment with drugs other than such allowed for Grade I Grade III:Requiring surgical, endoscopic or radiological intervention. Grade IV:Life-threatening complication (including CNS complications)* requiring IC/ICU-management with single or multiorgan disfunction.

Grade V: Death of a patient

2022-2024
Readmision index
Time Frame: 2022-2024
Percentage of readmission
2022-2024

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 15, 2025

Primary Completion (Estimated)

January 15, 2025

Study Completion (Estimated)

February 15, 2025

Study Registration Dates

First Submitted

December 17, 2024

First Submitted That Met QC Criteria

January 2, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 2, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • Appendicitis Textbook Outomes
  • CEIm number (Other Identifier: Hospital del Mar)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Time Frame

2025-2026

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Valid MeSH Conditions

Subscribe